Market Place
Sourcing Support
Tevogen CIO Mittul to Join Startup Forum at Databricks DATA + AI
10 Sep 2025 //
GLOBENEWSWIRE
Tevogen Forecasts $6.5B Revenue Over 5 Years for Liver Cancer
09 Sep 2025 //
GLOBENEWSWIRE
Tevogen Values TVGN-489 at $9-$11 B, First Product From Platform
08 Sep 2025 //
GLOBENEWSWIRE
Tevogen Shares Valuation, Pipeline Forecast on EBV Focus
04 Sep 2025 //
GLOBENEWSWIRE
Tevogen Bio Unveils Assets, Plans Valuation Disclosure
27 Aug 2025 //
GLOBENEWSWIRE
Tevogen Acknowledges to Yale for Recognizing Dr. Ryan Saadi
26 Aug 2025 //
GLOBENEWSWIRE
Tevogen Reports 72% Rise in Institutional Ownership in Q2 2025
25 Aug 2025 //
GLOBENEWSWIRE
Tevogen Honored in BINJE`s BEST 2025 for Health Equity, Biopharma
22 Aug 2025 //
GLOBENEWSWIRE
Tevogen Q2 & H1 2025 Results Show Lower Costs, Growth
19 Aug 2025 //
GLOBENEWSWIRE
Tevogen Bio Raises $50M for R&D and Clinical Development
19 Aug 2025 //
GLOBENEWSWIRE
Tevogen CEO Donates Personal Shares to Aid Brain Injury Recovery
18 Aug 2025 //
GLOBENEWSWIRE
Tevogen CEO Donates Personal Shares to Back Local Law Enforcement
18 Aug 2025 //
GLOBENEWSWIRE
Tevogen CEO Affirms Full Protection of Internal Assets
14 Aug 2025 //
GLOBENEWSWIRE
Tevogen.AI, Databrick, Expand PredicTcell Beta in Oncology
13 Aug 2025 //
GLOBENEWSWIRE
Tevogen CEO Confirms Growth, Capital Position, AI Expansion
11 Aug 2025 //
GLOBENEWSWIRE
Tevogen Forecasts $1B Revenue in Launch Year, $10-14B in 5 Years
11 Aug 2025 //
GLOBENEWSWIRE
Tevogen Reports 73% Growth in Institutional Ownership
08 Aug 2025 //
GLOBENEWSWIRE
Tevogen Gets $1 M to Speed Ai Drug Discovery, Stays Well Funded
07 Aug 2025 //
GLOBENEWSWIRE
Tevogen`s institutional ownership surges; 73% of holders boost
06 Aug 2025 //
GLOBENEWSWIRE
Tevogen.AI Expand Microsoft, Databricks Deal for Predictcell Beta
05 Aug 2025 //
GLOBENEWSWIRE
Tevogen Bio to Accept $1 Million Grant for AI Expansion Efforts
01 Aug 2025 //
GLOBENEWSWIRE
Tevogen CEO affirms strong growth, capital position, and AI
01 Aug 2025 //
GLOBENEWSWIRE
Tevogen Emphasizes 74% Insider Ownership for Long-Term Vision
30 Jul 2025 //
GLOBENEWSWIRE
Tevogen.AI Backs U.S. AI Plan, Advances Healthcare Innovation
28 Jul 2025 //
GLOBENEWSWIRE
Tevogen.AI Gets Global Patent for Immuno AI Technology
18 Jul 2025 //
GLOBENEWSWIRE
Tevogen Signs Intent for New In-House Cell Therapy Manufacturing
17 Jul 2025 //
GLOBENEWSWIRE
Tevogen.AI Eyes Faster Entry via AI Patient Match Post Alpha
16 Jul 2025 //
GLOBENEWSWIRE
Tevogen.AI, Microsoft Launch PredicTcell to Cut R&D Costs
14 Jul 2025 //
GLOBENEWSWIRE
Tevogen Opens HQ, CEO-Funded, To Boost R&D and AI
10 Jul 2025 //
GLOBENEWSWIRE
Tevogen CEO Contributes to Build-Out of New Headquarters
30 Jun 2025 //
GLOBENEWSWIRE
Tevogen Advances EBV T Cell Therapy Using AI Insights
18 Jun 2025 //
GLOBENEWSWIRE
Tevogen Expands HQ Due to AI and Generics Growth
09 Jun 2025 //
GLOBENEWSWIRE
Tevogen.AI Launches With Microsoft, Databricks Support
30 May 2025 //
GLOBENEWSWIRE
Tevogen Bio to Expand Pipeline for Patients Aged 65+
23 May 2025 //
GLOBENEWSWIRE
Tevogen To Share Updates On Pipeline And Strategy Before Meeting
22 May 2025 //
GLOBENEWSWIRE
Tevogen Bio`s Model Tackles Biopharma Challenges with Innovation
12 May 2025 //
GLOBENEWSWIRE
Tevogen to Share DRS Process Details Amid Shareholder Interest
02 May 2025 //
GLOBENEWSWIRE
CD8 Technology Signs Letter of Intent for Tevogen for Manufacturing
30 Apr 2025 //
GLOBENEWSWIRE
Tevogen CEO to Discuss Liquidity Strategies at BioNJ Conference
29 Apr 2025 //
GLOBENEWSWIRE
Tevogen Explains DRS Vs Brokerage Accounts to Shareholders
29 Apr 2025 //
GLOBENEWSWIRE
Tevogen shares skyrocket as $1B in revenue for oncology pipeline
29 Apr 2025 //
GLOBENEWSWIRE
Tevogen Bio Announces 2025 Annual Meeting
25 Apr 2025 //
GLOBENEWSWIRE
Tevogen Bio Secures Own Cell Therapy Production Facility
17 Apr 2025 //
GLOBENEWSWIRE
Tevogen Bio Commissions Databricks to Development of PredicTcell
15 Apr 2025 //
GLOBENEWSWIRE
Tevogen CEO to Discuss Liquidity Strategies at BioNJ Conference
14 Apr 2025 //
GLOBENEWSWIRE
Tevogen Bio at AI x Bio Philly Event Showcasing Leading AI Biotechs
08 Apr 2025 //
GLOBENEWSWIRE
Tevogen Bio: Insider Ownership at 74%; Management`s Conviction
07 Apr 2025 //
GLOBENEWSWIRE
Tevogen Bio CEO on NJBIZ 2025 Health Care Power List
26 Mar 2025 //
GLOBENEWSWIRE
Tevogen Bio names David E. Banko Global Head of Government Affair
25 Mar 2025 //
GLOBENEWSWIRE
Tevogen Bio Develops Unique T Cell Vaccine, Files USPTO Patent
10 Mar 2025 //
GLOBENEWSWIRE
Tevogen Bio CIO Mittul Mehta Speaks at Proskauer`s AI Panel
07 Mar 2025 //
GLOBENEWSWIRE
Tevogen Bio to Receive $8 M of Non-Dilutive Grant Funding
03 Mar 2025 //
GLOBENEWSWIRE
Tevogen Bio CEO Ryan Saadi Named To 2025 NJBIZ Power 100
28 Feb 2025 //
GLOBENEWSWIRE
Tevogen Bio Reports 600% Higher Market Cap Per Team Member
21 Feb 2025 //
GLOBENEWSWIRE
Tevogen Bio CEO Talks Short Selling’s Impact On Health
14 Feb 2025 //
GLOBENEWSWIRE
Tevogen Bio Shares 2024 Financing On 1-Year Public Listing
14 Feb 2025 //
GLOBENEWSWIRE
Tevogen Bio CEO Commits To Retention Of Equity Capital
14 Feb 2025 //
GLOBENEWSWIRE
Tevogen CEO Congratulates RFK Jr. On HHS Secretary Confirmation
13 Feb 2025 //
GLOBENEWSWIRE
Tevogen Bio Tackles Biopharma Challenges With Cost-Efficient Model
10 Feb 2025 //
GLOBENEWSWIRE
Tevogen Bio`s Business Model Address Biopharma Industry Challenges
10 Feb 2025 //
GLOBENEWSWIRE
